(Q46268487)

20 December 2017

title

Direct-to-consumer advertising of prescription drugs: balancing benefits and risks, and a way forward (English)

1 reference

20 December 2017

author

Richard L. Kravitz

series ordinal

1

1 reference

20 December 2017

author name string

Bell RA

series ordinal

2

1 reference

20 December 2017

language of work or name

English

0 references

publication date

1 October 2007

1 reference

20 December 2017

Clinical Pharmacology & Therapeutics

published in

1 reference

20 December 2017

volume

82

1 reference

20 December 2017

issue

4

1 reference

20 December 2017

page(s)

360-362

1 reference

20 December 2017

Creating demand for prescription drugs: a content analysis of television direct-to-consumer advertising.

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100348

7 January 2021

Time to ban direct-to-consumer prescription drug marketing

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100348

7 January 2021

Drug risks and free speech--can Congress ban consumer drug ads?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100348

7 January 2021

What are the public health effects of direct-to-consumer drug advertising?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100348

7 January 2021

Primary prevention of cardiovascular diseases with statin therapy: a meta-analysis of randomized controlled trials

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100348

7 January 2021

Use of statins in primary and secondary prevention of coronary heart disease and ischemic stroke. Meta-analysis of randomized trials.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100348

7 January 2021

Identifiers

DOI

10.1038/SJ.CLPT.6100348

1 reference

20 December 2017

1 reference

20 December 2017